X Chromosome Dose and Sex Bias in Autoimmune Diseases: Increased Prevalence of 47,XXX in Systemic Lupus Erythematosus and Sjögren's Syndrome
- PMID: 26713507
- PMCID: PMC5019501
- DOI: 10.1002/art.39560
X Chromosome Dose and Sex Bias in Autoimmune Diseases: Increased Prevalence of 47,XXX in Systemic Lupus Erythematosus and Sjögren's Syndrome
Abstract
Objective: More than 80% of autoimmune disease predominantly affects females, but the mechanism for this female bias is poorly understood. We suspected that an X chromosome dose effect accounts for this, and we undertook this study to test our hypothesis that trisomy X (47,XXX; occurring in ∼1 in 1,000 live female births) would be increased in patients with female-predominant diseases (systemic lupus erythematosus [SLE], primary Sjögren's syndrome [SS], primary biliary cirrhosis, and rheumatoid arthritis [RA]) compared to patients with diseases without female predominance (sarcoidosis) and compared to controls.
Methods: All subjects in this study were female. We identified subjects with 47,XXX using aggregate data from single-nucleotide polymorphism arrays, and, when possible, we confirmed the presence of 47,XXX using fluorescence in situ hybridization or quantitative polymerase chain reaction.
Results: We found 47,XXX in 7 of 2,826 SLE patients and in 3 of 1,033 SS patients, but in only 2 of 7,074 controls (odds ratio in the SLE and primary SS groups 8.78 [95% confidence interval 1.67-86.79], P = 0.003 and odds ratio 10.29 [95% confidence interval 1.18-123.47], P = 0.02, respectively). One in 404 women with SLE and 1 in 344 women with SS had 47,XXX. There was an excess of 47,XXX among SLE and SS patients.
Conclusion: The estimated prevalence of SLE and SS in women with 47,XXX was ∼2.5 and ∼2.9 times higher, respectively, than that in women with 46,XX and ∼25 and ∼41 times higher, respectively, than that in men with 46,XY. No statistically significant increase of 47,XXX was observed in other female-biased diseases (primary biliary cirrhosis or RA), supporting the idea of multiple pathways to sex bias in autoimmunity.
© 2016, American College of Rheumatology.
Figures



Similar articles
-
Rare X Chromosome Abnormalities in Systemic Lupus Erythematosus and Sjögren's Syndrome.Arthritis Rheumatol. 2017 Nov;69(11):2187-2192. doi: 10.1002/art.40207. Epub 2017 Oct 12. Arthritis Rheumatol. 2017. PMID: 28692793 Free PMC article.
-
Nationwide analysis of neuromyelitis optica in systemic lupus erythematosus and Sjogren's syndrome.Clin Rheumatol. 2024 Jan;43(1):59-65. doi: 10.1007/s10067-023-06809-z. Epub 2023 Nov 18. Clin Rheumatol. 2024. PMID: 37980305
-
Contribution of dendritic cell immunoreceptor (DCIR) polymorphisms in susceptibility of systemic lupus erythematosus and primary Sjogren's syndrome.Hum Immunol. 2015 Nov;76(11):808-11. doi: 10.1016/j.humimm.2015.09.040. Epub 2015 Sep 30. Hum Immunol. 2015. PMID: 26429306
-
The risk of lymphoma development in autoimmune diseases: a meta-analysis.Arch Intern Med. 2005 Nov 14;165(20):2337-44. doi: 10.1001/archinte.165.20.2337. Arch Intern Med. 2005. PMID: 16287762 Review.
-
Polyautoimmunity in Sjögren Syndrome.Rheum Dis Clin North Am. 2016 Aug;42(3):457-72. doi: 10.1016/j.rdc.2016.03.005. Epub 2016 Jun 21. Rheum Dis Clin North Am. 2016. PMID: 27431348 Review.
Cited by
-
The dynamic epigenetic regulation of the inactive X chromosome in healthy human B cells is dysregulated in lupus patients.Proc Natl Acad Sci U S A. 2021 Jun 15;118(24):e2024624118. doi: 10.1073/pnas.2024624118. Proc Natl Acad Sci U S A. 2021. PMID: 34103397 Free PMC article.
-
Neurological risks of COVID-19 in women: the complex immunology underpinning sex differences.Front Immunol. 2023 Nov 14;14:1281310. doi: 10.3389/fimmu.2023.1281310. eCollection 2023. Front Immunol. 2023. PMID: 38035090 Free PMC article.
-
Abnormal Epigenetic Regulations in the Immunocytes of Sjögren's Syndrome Patients and Therapeutic Potentials.Cells. 2022 May 27;11(11):1767. doi: 10.3390/cells11111767. Cells. 2022. PMID: 35681462 Free PMC article. Review.
-
DLA class II haplotypes show sex-specific associations with primary hypoadrenocorticism in Standard Poodle dogs.Immunogenetics. 2019 May;71(5-6):373-382. doi: 10.1007/s00251-019-01113-0. Epub 2019 Apr 9. Immunogenetics. 2019. PMID: 30968193
-
47XXY and 47XXX in Scleroderma and Myositis.ACR Open Rheumatol. 2022 Jun;4(6):528-533. doi: 10.1002/acr2.11413. Epub 2022 Mar 29. ACR Open Rheumatol. 2022. PMID: 35352506 Free PMC article.
References
-
- Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis and rheumatism. 2008;58(1):15–25. - PubMed
-
- Selmi C, Bowlus CL, Gershwin ME, Coppel RL. Primary biliary cirrhosis. Lancet. 2011;377(9777):1600–9. - PubMed
-
- Gabriel SE. The epidemiology of rheumatoid arthritis. Rheum Dis Clin North Am. 2001;27(2):269–81. - PubMed
-
- Massardo L, Pons-Estel BA, Wojdyla D, Cardiel MH, Galarza-Maldonado CM, Sacnun MP, et al. Early rheumatoid arthritis in Latin America: low socioeconomic status related to high disease activity at baseline. Arthritis care & research. 2012;64(8):1135–43. - PubMed
Publication types
MeSH terms
Supplementary concepts
Grants and funding
- U54 GM104938/GM/NIGMS NIH HHS/United States
- R56 AI063274/AI/NIAID NIH HHS/United States
- P30 AR053483/AR/NIAMS NIH HHS/United States
- MOP74621/CIHR/Canada
- R01 HL113326/HL/NHLBI NIH HHS/United States
- U01 AI101934/AI/NIAID NIH HHS/United States
- R01 AI024717/AI/NIAID NIH HHS/United States
- P01 AR048929/AR/NIAMS NIH HHS/United States
- P30 AR070549/AR/NIAMS NIH HHS/United States
- MOP89955/CIHR/Canada
- UL1 TR001417/TR/NCATS NIH HHS/United States
- P60 AR062755/AR/NIAMS NIH HHS/United States
- R01 AR057106/AR/NIAMS NIH HHS/United States
- R01 DE015223/DE/NIDCR NIH HHS/United States
- R01 DE018209/DE/NIDCR NIH HHS/United States
- R01 AI063274/AI/NIAID NIH HHS/United States
- RC1 AR058587/AR/NIAMS NIH HHS/United States
- P20 RR020143/RR/NCRR NIH HHS/United States
- U19 AI082714/AI/NIAID NIH HHS/United States
- P30 GM103510/GM/NIGMS NIH HHS/United States
- R21 AR065626/AR/NIAMS NIH HHS/United States
- P50 AR060804/AR/NIAMS NIH HHS/United States
- R01 AI031584/AI/NIAID NIH HHS/United States
- N01 AR062277/AR/NIAMS NIH HHS/United States
- P30 CA023108/CA/NCI NIH HHS/United States
- R01 AR056360/AR/NIAMS NIH HHS/United States
- R01 AR052125/AR/NIAMS NIH HHS/United States
- U19 AI062629/AI/NIAID NIH HHS/United States
- U01 HG006828/HG/NHGRI NIH HHS/United States
- R01 AR043814/AR/NIAMS NIH HHS/United States
- R37 AI024717/AI/NIAID NIH HHS/United States
- R01 AR042460/AR/NIAMS NIH HHS/United States
- I01 BX001451/BX/BLRD VA/United States
- P50 AR048940/AR/NIAMS NIH HHS/United States
- R01 AR053734/AR/NIAMS NIH HHS/United States
- G0800629/MRC_/Medical Research Council/United Kingdom
- RC2 AR058959/AR/NIAMS NIH HHS/United States
- P01 AI083194/AI/NIAID NIH HHS/United States
- P01 AR049084/AR/NIAMS NIH HHS/United States
- P30 AR047363/AR/NIAMS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical